Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-005014·Ayala Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
OS THERAPIES INCORPORATED
Common Stock, par value $0.001 per share · CUSIP: 68764Y207
Event date: 2025-04-09
- Filing-level shares
- 2,164,215.00
- Percent of class
- 9.99%
- AYALA PHARMACEUTICALS, INC.
Shares: 2,164,215.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-005014
- Form type
- SCHEDULE 13G
- Filer
- Ayala Pharmaceuticals, Inc.
- CIK
- CIK 1100397
- Filed
- Apr 16, 2025
- Reporting period
- Apr 09, 2025
- Description
- Schedule 13G beneficial ownership